Clinical Trial Update: Matrix Metalloproteinase-1/Tissue Inhibitor of Metalloproteinase-1 (MMP-1/TIMP-1) Ratio and Diabetic Foot Ulcers [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial studying the MMP-1/TIMP-1 ratio in diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Diabetic Foot Ulcer | EARLY_Phase 1 | Status: COMPLETED